Literature DB >> 9776662

Influence of genuine kavapyrone enantiomers on the GABA-A binding site.

G Boonen1, H Häberlein.   

Abstract

The influence of kavapyrones from Piper methysticum Forst. on the GABAA receptor was demonstrated using radioreceptor assays. Both the dienolide yangonin and the genuine enolide enantiomers (+)-kavain, (+)-dihydrokavain, (+)-methysticin, and (+)-dihydromethysticin enhanced the specific binding of [3H]bicuculline methochloride ([3H]BMC). The kavapyrones have been investigated at assay concentrations between 100 microM and 10 nM. (+)-Kavain, (+)-methysticin and (+)-dihydromethysticin showed maximal enhancements of 18% to 28% at a concentration of 0.1 microM, whereas a 100-fold concentration of (+)-dihydrokavain revealed a similar modulatory activity of 22%. In the presence of 1 microM yangonin an increase of about 21% of the specific [3H]BMC binding was observed. Desmethoxyyangonin did not alter the binding behavior of the GABAA-receptor. A structure comparison of desmethoxyyangonin and yangonin indicated that the aromatic methoxy group was of particular importance for the modulatory activity. In contrast, the substitution pattern of the aromatic ring did not influence the modulatory activity of the enolides in a decisive manner. A structure comparison of desmethoxyyangonin and (+)-kavain revealed that an angular lactone ring was an important structure requirement. Both the enolides and the dienolides did not inhibit the specific binding of [3H]flunitrazepan. Thus, the influence on the GABAA receptor was not based upon an interaction of these kavapyrones with the benzodiazepine receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776662     DOI: 10.1055/s-2006-957502

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers.

Authors:  Yi Wang; Sreekanth C Narayanapillai; Katelyn M Tessier; Lori G Strayer; Pramod Upadhyaya; Qi Hu; Rick Kingston; Ramzi G Salloum; Junxuan Lu; Stephen S Hecht; Dorothy K Hatsukami; Naomi Fujioka; Chengguo Xing
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-26

Review 2.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Effects of kava-kava extract on the sleep-wake cycle in sleep-disturbed rats.

Authors:  Kazuaki Shinomiya; Toshio Inoue; Yoshiaki Utsu; Shin Tokunaga; Takayoshi Masuoka; Asae Ohmori; Chiaki Kamei
Journal:  Psychopharmacology (Berl)       Date:  2005-02-08       Impact factor: 4.530

4.  Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.

Authors:  Kennon M Garrett; Garo Basmadjian; Ikhlas A Khan; Brian T Schaneberg; Thomas W Seale
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

5.  A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis elegans Neuromuscular Transmission.

Authors:  Bwarenaba B Kautu; Juliana Phillips; Kellie Steele; M Shawn Mengarelli; Eric A Nord
Journal:  J Exp Neurosci       Date:  2017-06-05

6.  Synthetic Kavalactone Analogues with Increased Potency and Selective Anthelmintic Activity against Larvae of Haemonchus contortus In Vitro.

Authors:  H M P Dilrukshi Herath; Aya C Taki; Nghi Nguyen; José Garcia-Bustos; Andreas Hofmann; Tao Wang; Guangxu Ma; Bill C H Chang; Abdul Jabbar; Brad E Sleebs; Robin B Gasser
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

7.  Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.

Authors:  J Sarris; S Moylan; D A Camfield; M P Pase; D Mischoulon; M Berk; F N Jacka; I Schweitzer
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

8.  Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

Authors:  Han Chow Chua; Emilie T H Christensen; Kirsten Hoestgaard-Jensen; Leonny Y Hartiadi; Iqbal Ramzan; Anders A Jensen; Nathan L Absalom; Mary Chebib
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

9.  Evaluation of the Sleep-Prolonging Effect of Lagenaria vulgaris and Cucurbita pepo Extracts on Pentobarbital-Induced Sleep and Possible Mechanisms of Action.

Authors:  Vafa Baradaran Rahimi; Vahid Reza Askari; Amineh Sadat Tajani; Azar Hosseini; Hassan Rakhshandeh
Journal:  Medicina (Kaunas)       Date:  2018-07-31       Impact factor: 2.430

Review 10.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.